Your browser doesn't support javascript.
loading
Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
Sehjal, Jyoti; Sharples, Linda D; Keogh, Ruth H; Walker, Kate; Prachalias, Andreas; Heaton, Nigel; Ivanics, Tommy; van der Meulen, Jan; Wallace, David.
Afiliação
  • Sehjal J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Sharples LD; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Keogh RH; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Walker K; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Prachalias A; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Heaton N; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Ivanics T; Division of General Surgery, Multi-organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
  • van der Meulen J; Department of Surgery, Henry Ford Hospital, Detroit, MI.
  • Wallace D; Department of Surgical Sciences, Akademiska Sjukhuset, Uppsala University, Uppsala, Sweden.
Transplantation ; 106(11): e464-e475, 2022 11 01.
Article em En | MEDLINE | ID: mdl-36017919
BACKGROUND: Accurately identifying time-varying differences in the hazard of all-cause mortality after liver transplantation (LT) between recipients with and without hepatocellular carcinoma (HCC) may inform patient selection and organ allocation policies as well as post-LT surveillance protocols. METHODS: A UK population-based study was carried out using 9586 LT recipients. The time-varying association between HCC and post-LT all-cause mortality was estimated using an adjusted flexible parametric model (FPM) and expressed as hazard ratios (HRs). Differences in this association by transplant year were then investigated. Non-cancer-specific mortality was compared between HCC and non-HCC recipients using an adjusted subdistribution hazard model. RESULTS: The HR comparing HCC recipients with non-HCC recipients was below one immediately after LT (1-mo HR = 0.76; 95% confidence interval [CI], 0.59-0.99; P = 0.044). The HR then increased sharply to a maximum at 1.3 y (HR = 2.07; 95% CI, 1.70-2.52; P < 0.001) before decreasing. The hazard of death was significantly higher in HCC recipients than in non-HCC recipients between 4 mo and 7.4 y post-LT. There were no notable differences in the association between HCC and the post-LT hazard of death by transplant year. The estimated non-cancer-specific subdistribution HR for HCC was 0.93 (95% CI, 0.80-1.09; P = 0.390) and not found to vary over time. CONCLUSIONS: FPMs can provide a more precise comparison of post-LT hazards of mortality between HCC and non-HCC patients. The results provide further evidence that some HCC patients have extra-hepatic spread at the time of LT, which has implications for optimal post-LT surveillance protocols.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article